Pregabalin-Related Memory Impairment: Management Approach
You should discuss with your prescribing physician a gradual dose reduction or discontinuation of pregabalin, as cognitive impairment—particularly affecting concentration, attention, and memory—is a well-documented adverse effect that may improve after stopping the medication.
Understanding the Problem
Pregabalin commonly causes cognitive side effects, and your experience aligns with established evidence. The FDA drug label explicitly lists "trouble concentrating" as one of the most common side effects of LYRICA (pregabalin) 1. Clinical guidelines note that pregabalin can produce dose-dependent dizziness and sedation 2, and cognitive effects are part of this spectrum.
Evidence of Cognitive Impact
Recent high-quality research confirms your concerns:
A 2023 meta-analysis found that pregabalin administration in clinical studies showed transient CNS side effects in healthy volunteers, though it did not demonstrate memory-improving effects 3
A 2023 population-based study of over 200,000 patients found that pregabalin exposure increased dementia risk (hazard ratio 1.45), with risk increasing at higher cumulative doses 4
A 2010 Class I evidence study in healthy volunteers showed pregabalin 300 mg twice daily negatively impacted cognition on multiple tasks, including Digit Symbol, Stroop, and word association tests, with parallel complaints on neurotoxicity scales 5
A 2019 perioperative study demonstrated pregabalin significantly impaired executive functioning, including inhibition and working memory 6
Recommended Action Steps
1. Do Not Stop Abruptly
The FDA label explicitly warns: "Do not stop taking LYRICA without talking to your healthcare provider. If you stop taking LYRICA suddenly you may have headaches, nausea, diarrhea, trouble sleeping, increased sweating, or you may feel anxious" 1. A withdrawal syndrome is well-documented, requiring gradual tapering 1.
2. Initiate Physician-Supervised Tapering
- Schedule an appointment with your prescribing physician immediately
- Discuss a gradual dose reduction protocol tailored to your specific indication (neuropathic pain, seizures, fibromyalgia, etc.)
- The taper should be slow enough to avoid withdrawal symptoms while monitoring for return of your original condition
3. Consider Alternative Treatments
Depending on your original indication, discuss alternatives with your physician:
- For neuropathic pain: Duloxetine, tricyclic antidepressants (nortriptyline), gabapentin (though it has similar cognitive effects), or topical lidocaine for localized pain 2
- For other conditions: Treatment should be individualized based on your specific diagnosis
4. Monitor Cognitive Recovery
- Cognitive effects may be reversible after discontinuation, though the timeline varies
- Keep a symptom diary to track memory improvements during and after tapering
- If memory problems persist 2-3 months after complete discontinuation, further neurological evaluation may be warranted
Important Caveats
Common pitfall: Patients often stop medications abruptly when experiencing side effects. With pregabalin, this creates additional problems through withdrawal symptoms and potential worsening of the underlying condition being treated.
Dose-dependency: Your 150 mg daily dose is at the lower end of the therapeutic range (typical range 150-600 mg/day) 2, yet cognitive effects can occur even at this dose 5.
Duration matters: You've been on pregabalin for two years, which represents chronic exposure. The 2023 study showed that cumulative dose increases dementia risk 4, making your concern about long-term cognitive effects particularly valid.
Quality of life priority: While pregabalin may control your pain or other symptoms, significant memory impairment substantially reduces quality of life. The risk-benefit balance may have shifted unfavorably, warranting medication reassessment.
The Bottom Line
Your short-term memory impairment is likely medication-related and represents a legitimate reason to reconsider pregabalin therapy. Work with your physician to develop a safe discontinuation plan while addressing your underlying condition through alternative approaches. The cognitive effects are well-documented in both FDA labeling 1 and recent high-quality research 4, 6, 5, making this a medically sound decision rather than simply tolerating a troublesome side effect.